1. CT‐measured skeletal muscle mass used to assess frailty in patients with head and neck cancer
- Author
-
Aniek T. Zwart, Anouk van derHoorn, Peter M.A. vanOoijen, Roel J.H.M. Steenbakkers, Geertruida H. deBock, and Gyorgy B. Halmos
- Subjects
Sarcopenia ,Head and neck neoplasms ,Computer‐assisted image analysis ,Frailty ,Malnutrition ,Mobility limitation ,Diseases of the musculoskeletal system ,RC925-935 ,Human anatomy ,QM1-695 - Abstract
Abstract Background Skeletal muscle depletion or sarcopenia is related to multiple adverse clinical outcome. However, frailty questionnaires are currently applied in the daily practice to identify patients who are potentially (un)suitable for treatment but are time consuming and straining for patients and the clinician. Screening for sarcopenia in patients with head and neck cancer (HNC) could be a promising fast biomarker for frailty. Our objective was to quantify sarcopenia with pre‐treatment low skeletal muscle mass from routinely obtained neck computed tomography scans at level of third cervical vertebra in patients diagnosed with HNC and evaluate its association with frailty. Methods A total of 112 HNC patients with Stages III and IV disease were included from a prospective databiobank. The amount of skeletal muscle mass was retrospectively defined using the skeletal muscle index (SMI). Correlation analysis between SMI and continuous frailty data and the observer agreement were analysed with Pearson's r correlation coefficients. Sarcopenia was present when SMI felt below previously published non‐gender specific thresholds (
- Published
- 2019
- Full Text
- View/download PDF